Optimized human cell products for research
and drug discovery

Security Policy

DefiniGEN uses all reasonable precautions to keep the information disclosed to us secure. DefiniGEN reserves the right to transfer information in connection with the sale of all or part of the DefiniGEN capital stock or assets to any third party. Furthermore, we are not responsible for any breach of security or for any actions of any third parties that receive the information.